The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
Sponsored by University of California, San Francisco
About this trial
Last updated a year ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Started 15 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
1. Able to give informed consent
2. No contraindication to surgical procedures
3. Palpable inguinal adenopathy at study entry
4. For HIV seropositive subjects, meeting one of the following criteria: (1) on stable highly active antiretroviral therapy (HAART) with a recent undetectable viral load (< 50 copies/mL) ("HAART suppressed"), (2) antiretroviral untreated with an undetectable viral load (< 50 copies/mL) ("elite" controllers), or (3) antiretroviral untreated with a detectable viral load (> 1000 copies/mL) ("non-controllers")
Exclusion Criteria
1. Known anemia (HIV+ males Hct<34; females Hct<32) or contraindication to donating blood
2. Blood coagulation disorder (including bleeding tendency or problems in past with blood clots)
3. Platelets < 50,000/mm3
4. PTT > 2x ULN
5. INR > 1.5
6. Pregnant
